ZRSR2 and cancer: Notably, loss-of-function mutations in ZRSR2 cause widespread minor intron retention and thus enhance hematopoietic stem cell self-renewal as well as drive diverse cancer predisposition, which putatively results from LZTR1 minor intron retention (Inoue et al. 2021).